Back to search

Article

A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials

2023-05-26

Abstract excerpt

<h4>Purpose: </h4> To investigate the trade-off between survival outcome and quality of life (QoL) in Multiple Myeloma (MM). Methods We developed a questionnaire that asked patients amongst others, whether they would choose a shortened time of progression-free survival (PFS) in favor of an increased QoL Results Of 194 MM patients who answered this question, 81 (42%) subjects were willing to accept a shorter PFS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8e660e31-237c-50fa-84d9-5f56b7452d1b
DOI
10.21203/rs.3.rs-2975755/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trialsDOI 10.21203/rs.3.rs-2975755/v1
Multiple myeloma: patient outcomes in real-world practice.Semantic proximity
Patient Preferences for Treatment‑Free Intervals in Multiple Myeloma: Mixed‑Methods Insights on Monitoring Trade‑offs and Supportive Care ImprovementsSemantic proximity
Patient Experience with Treatment of Relapsed or Refractory Multiple Myeloma (RRMM): Content Validity of the Satisfaction and Experience Questionnaire (SEQ)-MMSemantic proximity
Multiple Myeloma and Physical ActivitySemantic proximity
Quality-Of-Life Survey of Pancreatic Cancer Patients: A Comparison Between General Public and PhysiciansSemantic proximity
Identification of Preference "Phenotypes" in Men With Prostate Cancer.Semantic proximity
Increased LDH Remains a Crucial Prognostic Factor in Patients with Multiple Myeloma.Semantic proximity
Haematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-line Treatment With a Bortezomib-based RegimenSemantic proximity
Select a neighboring publication to make it the new centre.